Business Wire

AVENIR-GLOBAL

3.4.2019 15:32:11 CEST | Business Wire | Press release

Share
AVENIR GLOBAL Continues to Build Global Powerhouse of Specialist Communications Firms with Acquisition of Hanover

AVENIR GLOBAL, a Montreal-based holding and management company of public relations and communications firms, today announced that it has acquired Hanover, a top 10 independent U.K. public relations consultancy with offices in London, Brussels, Dublin, Dubai and Abu Dhabi.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190403005503/en/

With the acquisition of Hanover, AVENIR GLOBAL consists of 1,000 employees in 25 locations across North America, Europe and the Middle East. Its annualized revenue of £125M should place the firm in the top 15 worldwide public relations agency ranking.

This transaction is part of a strategic plan to build a global powerhouse of specialist communications firms delivering outstanding value to clients. Together with the November 2018 acquisition of London-based healthcare creative agency, Cherry, the deal significantly enhances AVENIR GLOBAL’s EMEA offering. The group was already represented in the region by healthcare communications firm AXON Communications, with offices in London, Copenhagen, Zug, Brighton, New York and Toronto, and by its strategic communications consultancy Madano Partnership.

“We are building a powerful network of colleagues who are the best in their field and our goal is to provide our clients with bold thinking founded on research, insights and deep sector expertise. Hanover is hugely respected as one of the best and fastest growing agencies in the world and this transaction showcases our ambitions. In addition to an enhanced geographic footprint, there is a strong cultural alignment, which is critical to our teams working well together,” said Ralph Sutton, International Managing Partner of AVENIR GLOBAL.

“Hanover focuses on communications and public affairs disciplines which are key to our network, in addition to deep sectoral expertise in healthcare, financial services, technology, media, energy, fast-moving consumer goods, industrials and sport. The combined business in the U.K. places us among the country’s largest public relations consultancies; second in public affairs and first in healthcare.”

Founded in London in 1998 by CEO Charles Lewington, Hanover is one of Europe’s leading strategic communications and public affairs consultancies with 163 employees, advising global companies on building recognition and enhancing reputation. Clients include Goldman Sachs, Airbus, Microsoft, Apple, Warner Media, Sky, Lucozade Ribena Suntory, Premier League, Tata Steel, Lilly, Novartis, BMS, Roche and Takeda. The Hanover Group also includes creative communications agency The Playbook, and Multiple, a brand and culture consultancy that enables technology challengers and corporate change-makers to define their purpose, fire up their people and build platforms for growth. The agency’s leadership team will remain in place following the transaction.

AVENIR GLOBAL has 300 healthcare communications staff harnessing expertise in public relations, reputation management, crisis and issues management, medical communications, clinical trial support, marketing communications, public affairs, market access and internal communications. The firm works for many of the largest names in the pharmaceutical and medical device industries as well as working with healthcare providers, technology firms and patient advocacy organisations.

Other sectors where the combined group will have particular strength on both sides of the Atlantic include food and drink, energy and financial services, and the communications disciplines of reputation management, public affairs and issues and crisis management.

“AVENIR GLOBAL provided a strong business case for joining forces to create an unrivalled worldwide team of specialist communications firms. We share a common belief in building a high degree of client service and expertise,” said Charles Lewington.

“By joining the AVENIR GLOBAL network, we broaden our offering in insights and research, add impressive resources in creative and digital campaigning and execution, and can draw on additional scientific expertise in healthcare, food and drink, and energy. Our international clients also now have access to a strong presence in North America which will help us meet their international communications objectives.’

The Fonds de solidarité FTQ and Bank of Montreal provided the cross border financing for the transaction.

About AVENIR GLOBAL

AVENIR GLOBAL is a Montreal-based holding and management company with an active operations mindset and a hands-on approach to all its investments. A global powerhouse of specialist communications firms, AVENIR GLOBAL has 1,000 staff and offices in 25 locations across Canada, the U.S., Europe and the Middle East, and ranks among the top 15 largest communication firms in the world.

In Canada, AVENIR GLOBAL owns NATIONAL Public Relations , the country’s leading public relations firm, servicing clients across a wide range of sectors, which includes NATIONAL Capital Markets , the industry’s foremost investor relations and financial services practice. In the United States, AVENIR GLOBAL owns SHIFT Communications , a data-driven integrated communications agency; and the public relations and communication company Padilla , which includes the brand consultancy Joe Smith , the food and nutrition experts at FoodMinds and the research authorities at SMS Research Advisors . In Europe, AVENIR GLOBAL owns the London-based strategic communications consultancy Madano and Hanover , one of the EMEA’s leading strategic communications and public affairs consultancies, with offices in London, Brussels, Dublin, Dubai and Abu Dhabi. Hanover Group also includes creative communications agency The Playbook , and the brand and culture consultancy Multiple . The AVENIR GLOBAL network also includes healthcare specialists AXON Communications , with offices in Toronto, the U.S, the U.K. and Europe and healthcare creative agency Cherry , based in London.

AVENIR GLOBAL is owned by RES PUBLICA Consulting Group .

About Hanover

Hanover is one of Europe’s leading strategic communications and public affairs consultancies, with offices in London, Brussels, Dublin, Dubai and Abu Dhabi. Hanover Group also includes creative communications agency The Playbook , and Multiple , a brand and culture consultancy that enables technology challengers and corporate change-makers to define their purpose, fire up their people and build platforms for growth.

Hanover Group has 163 full-time employees across Europe and 2018 revenue of £19m. It has delivered consistent 25% top-line growth over the past four years, and plans to double the size of the company by 2022.

Hanover provides a full suite of communications services to clients in healthcare, financial services, technology, media, energy, FMCG, industrial, and sport. Its blue-chip client list includes Goldman Sachs, Airbus, Microsoft, Warner Media, Sky, Lilly, Lucozade Ribena Suntory, Tata Steel, Novartis, BMS, Roche, and Takeda.

Hanover is now an AVENIR GLOBAL company.

Contact:

INFORMATION: AVENIR GLOBAL Ralph Sutton +44 (0) 7803 899576. rsutton@avenir.global

Hanover Laura Roberts +44 (0) 7791 501992 lroberts@hanovercomms.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release

The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye